Record annual revenue and adjusted EBITDA of $257.8 million and $103.1 million; annual EPS (diluted) $1.43 Strong high -value ...
The truth about "El Niño" ...
Tejon Ranch (NYSE:TRC) executives used the company’s fourth-quarter 2025 earnings call to highlight improved operating performance, continued cost-cutting initiatives, and progress on governance ...
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results